Pharmaceuticals

Intranasal Corticosteroids Market Growth Projection: Expected to Surpass $9.74 Billion by 2030 at 7.4% CAGR

February 16, 2026March 11, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the intranasal corticosteroids market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Intranasal Corticosteroids Market reach by 2030 starting from 2026 levels?

The market for intranasal corticosteroids has experienced robust expansion in recent years. This market is projected to increase from $6.78 billion in 2025 to $7.31 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.8%. The growth observed in the preceding period was influenced by factors such as a limited understanding of intranasal corticosteroids, a reliance on hospital pharmacies for drug distribution, an escalating incidence of nasal allergies, a preference for traditional treatment methods, and restricted availability of online pharmacies.

The intranasal corticosteroids market size is projected to experience robust expansion in the upcoming years. Its valuation is expected to climb to $9.74 billion by 2030, progressing at a compound annual growth rate (CAGR) of 7.4%. This anticipated growth throughout the forecast period stems from factors such as increasing healthcare awareness, the expansion of retail and online pharmacies, a rising occurrence of chronic rhinitis and nasal polyps, the integration of combination therapies, and the advancement of patient-friendly spray devices. Significant trends foreseen during this period include a growing prevalence of allergic rhinitis and nasal disorders, a greater uptake of prescription intranasal corticosteroids, an increase in the use of over-the-counter intranasal corticosteroids, the broadening of hospital and homecare distribution channels, and a focus on patient-centric treatment with simplified administration.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25799&type=smp

Which Drivers Are Influencing Long-Term Growth In The Intranasal Corticosteroids Market?

The rising occurrence of allergic rhinitis is anticipated to drive the expansion of the intranasal corticosteroids market in the future. Allergic rhinitis constitutes an allergic response leading to inflammation within the nasal passages, commonly initiated by airborne allergens like pollen, dust mites, mold, or pet dander. The growing incidence of allergic rhinitis is mainly attributed to escalating environmental pollution, which exposes individuals to airborne allergens and irritants, thus prompting allergic reactions in the nasal passages. Intranasal corticosteroids assist in managing allergic rhinitis by diminishing inflammation within the nasal passages, thereby alleviating symptoms such as sneezing, congestion, and a runny nose. For example, data from October 2023, sourced from the National Library of Medicine, a US-based biomedical library, indicates that allergic rhinitis impacts more than 400 million people globally. Its prevalence rates are estimated at 10% to 30% among adults and over 40% in children. Consequently, the expanding prevalence of allergic rhinitis is fueling the intranasal corticosteroid market.

How Is The Intranasal Corticosteroids Market Divided Into Segments?

The intranasal corticosteroids market covered in this report is segmented –

1) By Drug Types: Prescribed Drugs, Over-The-Counter Drugs

2) By Application: Allergic Rhinitis, Nasal Polyps, Sinusitis, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel

4) By End User: Hospitals, Clinics, Homecare, Healthcare Providers

Subsegments:

1) By Prescribed Drugs: Fluticasone Propionate, Mometasone Furoate, Budesonide, Beclomethasone Dipropionate, Ciclesonide

2) By Over-The-Counter Drugs: Triamcinolone Acetonide, Fluticasone Furoate, Budesonide Over-The-Counter Drugs

What Long-Term Trends Are Expected To Shape The Future Of The Intranasal Corticosteroids Market?

Leading companies in the intranasal corticosteroids market are prioritizing the development of innovative formulations, such as nasal sprays, to improve targeted medication delivery and boost patient adherence. Nasal sprays are liquid drug applications administered directly into the nose via a spray nozzle, used to treat conditions including allergies, congestion, or inflammation. They facilitate rapid drug absorption through the nasal mucosa, providing quick relief with minimal systemic effects. For instance, in March 2024, OptiNose Inc., a US-based pharmaceutical company, gained approval from the U.S. Food and Drug Administration (FDA) for XHANCE, which is the first and only treatment specifically indicated for adults experiencing chronic rhinosinusitis (CRS) without nasal polyps. This nasal spray features a distinctive exhalation delivery system, allowing the medication to reach deep within the nasal cavity, thereby effectively treating CRS in adults, with or without nasal polyps. Each spray delivers 93 mcg of fluticasone propionate, and the device operates when the user exhales into a mouthpiece while simultaneously activating the spray into the nostril, ensuring precise delivery and improved symptom relief.

Which Major Industry Participants Are Leading The Intranasal Corticosteroids Market Growth?

Major companies operating in the intranasal corticosteroids market are GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Haleon plc, Intas Pharmaceuticals Limited, Organon Pharma (UK) Limited, Sun Pharmaceutical Industries Ltd., Apotex Inc., Perrigo Company plc, Aurobindo Pharma Limited, Cipla Ltd., Hikma Pharmaceuticals plc, Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Limited, OptiNose US Inc., Taro Pharmaceutical Industries Ltd., Maya Biotech Private Limited, AdvaCare Pharma USA, Lupin Ltd., Xenone Healthcare Private Limited.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/intranasal-corticosteroids-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Intranasal Corticosteroids Market?

North America was the largest region in the intranasal corticosteroids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intranasal corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Intranasal Corticosteroids Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25799&type=smp

Browse Through More Reports Similar to the Global Intranasal Corticosteroids Market 2026, By The Business Research Company

Internal Nasal Dilators Market Report 2026

https://www.thebusinessresearchcompany.com/report/internal-nasal-dilators-global-market-report

Corticosteroid Market Report 2026

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Intranasal Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795